摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

呋喃-2-基甲基-噻唑-2-基-胺 | 1041508-22-8

中文名称
呋喃-2-基甲基-噻唑-2-基-胺
中文别名
——
英文名称
N-(furan-2-ylmethyl)-1,3-thiazol-2-amine
英文别名
——
呋喃-2-基甲基-噻唑-2-基-胺化学式
CAS
1041508-22-8
化学式
C8H8N2OS
mdl
MFCD11518854
分子量
180.23
InChiKey
NMQMOLVKKJVZJZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    66.3
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors
    摘要:
    A series of heteroaryl-substituted bis-trifluoromethyl carbinols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Some thiazole-based derivatives showed potent in vitro MCD inhibitory activities and significantly increased glucose oxidation rates in isolated working rat hearts. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.03.100
  • 作为产物:
    描述:
    1-(呋喃-2-基)-N-(1,3-噻唑-2-基)甲亚胺 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 生成 呋喃-2-基甲基-噻唑-2-基-胺
    参考文献:
    名称:
    Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors
    摘要:
    A series of heteroaryl-substituted bis-trifluoromethyl carbinols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Some thiazole-based derivatives showed potent in vitro MCD inhibitory activities and significantly increased glucose oxidation rates in isolated working rat hearts. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.03.100
点击查看最新优质反应信息

文献信息

  • [EN] IMIDAZOPYRIDINE AND IMIDAZOPYRAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS D'IMIDAZOPYRIDINE ET D'IMIDAZOPYRAZINE UTILISÉS COMME INHIBITEURS DE KINASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2009155388A1
    公开(公告)日:2009-12-23
    A compound of Formula (I) or Formula (II) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) or Formula (II), and methods of treating conditions associated with the activity of p38 kinase.
    一种由化合物(I)或化合物(II)及其对映体、二对映体和药学上可接受的盐组成的复合物。还公开了含有化合物(I)或化合物(II)的药物组合物,以及治疗与p38激酶活性相关疾病的方法。
  • [EN] TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS DE TRIAZOLOPYRIDINE UTILISÉS COMME INHIBITEURS DE KINASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2009155389A1
    公开(公告)日:2009-12-23
    A compound of Formula (I) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula (I), and methods of treating conditions associated with the activity of p38 kinase.
    一种由式(I)的化合物及其对映体、二对映体和药用可接受的盐组成的混合物。还公开了含有式(I)化合物的药物组合物,以及治疗与p38激酶活性相关疾病的方法。
查看更多